Health ❯ Mental Health ❯ Schizophrenia

Treatment Options

Antipsychotic Medications Public Awareness Crisis Intervention Cobenfy Drug Efficacy Clinical Trials Societal Impact Institutionalization Public Health Policy Long-Acting Injectables Medication Long-acting Injectables Crisis Management Personal Stories New Treatments Stigma Reduction Impact on Behavior

FDA Approves Vanda’s Bysanti for Bipolar I Mania and Schizophrenia

Vanda secured clearance using bridged iloperidone evidence to speed the review.

Parkland Survivor Donovan Metayer, 26, Dies by Suicide After Risk Order Lapses

FDA Clears Monthly Uzedy Injection for Maintenance Treatment of Bipolar I Disorder

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.